• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Education and imaging. Gastrointestinal: Improvement of granuloma annulare with anti-tumour necrosis factor alpha therapy for Crohn's disease.

作者信息

Fanning Scott B, Chapman Grace, Yau Yunki, Leong Rupert W L

机构信息

Gastroenterology and Liver Services, Concord Hospital, Sydney South West Area Health Service, Sydney, Australia.

出版信息

J Gastroenterol Hepatol. 2010 Jan;25(1):215. doi: 10.1111/j.1440-1746.2009.06098.x.

DOI:10.1111/j.1440-1746.2009.06098.x
PMID:20136975
Abstract
摘要

相似文献

1
Education and imaging. Gastrointestinal: Improvement of granuloma annulare with anti-tumour necrosis factor alpha therapy for Crohn's disease.教育与影像学。胃肠道：抗肿瘤坏死因子α治疗克罗恩病使环状肉芽肿改善。
J Gastroenterol Hepatol. 2010 Jan;25(1):215. doi: 10.1111/j.1440-1746.2009.06098.x.
2
Successful treatment of disseminated granuloma annulare with adalimumab.阿达木单抗成功治疗播散性环状肉芽肿。
J Drugs Dermatol. 2009 Feb;8(2):169-71.
3
Certolizumab (Cimzia) for Crohn's disease.赛妥珠单抗（希敏佳）用于治疗克罗恩病。
Med Lett Drugs Ther. 2008 Oct 20;50(1297):81-2.
4
Generalized interstitial granuloma annulare--response to adalimumab.泛发性环状肉芽肿--阿达木单抗治疗的疗效。
Int J Dermatol. 2010 Apr;49(4):457-60. doi: 10.1111/j.1365-4632.2010.04348.x.
5
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.如何管理难治性克罗恩病：抗TNF药物的最佳给药方式
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):407-15. doi: 10.1586/egh.09.25.
6
Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.阿达木单抗治疗克罗恩病致严重心肌病。
Eur J Heart Fail. 2009 Nov;11(11):1106-9. doi: 10.1093/eurjhf/hfp132.
7
[Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].[阿达木单抗用于英夫利昔单抗难治性克罗恩病——下一代抗TNF-α疗法？]
Z Gastroenterol. 2005 Jul;43(7):689-90. doi: 10.1055/s-2005-858274.
8
Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?体重校正的抗肿瘤坏死因子治疗是否有利于肥胖的克罗恩病患者？
Eur J Gastroenterol Hepatol. 2013 May;25(5):543-9. doi: 10.1097/MEG.0b013e32835d1f15.
9
Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.阿达木单抗诱导的狼疮性红斑，发生于既往接受英夫利昔单抗治疗的克罗恩病患者。
Gut. 2008 Apr;57(4):559; author reply 559-60.
10
Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study.阿达木单抗治疗克罗恩病患者——一项开放标签单中心研究的安全性与疗效
Aliment Pharmacol Ther. 2007 Apr 1;25(7):787-96. doi: 10.1111/j.1365-2036.2007.03253.x.

引用本文的文献

1
Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.炎症性皮肤肉芽肿性疾病的分子靶向治疗：证据综述及对理解疾病发病机制的启示
JID Innov. 2023 Aug 10;3(5):100220. doi: 10.1016/j.xjidi.2023.100220. eCollection 2023 Sep.